Optimizing the treatment of patients with acute non-streptococcal tonsillopharyngitis: focusing on the impact on all stages of the etiopathogenesis
- 18 November 2026
- journal article
- Published by Media Sphere Publishing Group in Russian Bulletin of Otorhinolaryngology
- Vol. 91 (5)
Abstract
Acute tonsillopharyngitis (ATP) is one of the most common reasons for patients seeking primary care in both pediatric and adult practice. This disease is characterized by inflammatory changes in the mucosa and lymphatic structures of the oropharynx. The etiological structure of ATP is heterogeneous, but viruses play a leading role. Despite the long-term scientific and practical interest of doctors in the study of etiopathogenesis and the treatment of patients with this pathology, a significant number of diagnostic and therapeutic errors remain in real clinical practice, leading to polypharmacy and, first of all, to the unjustified prescription of systemic antibacterial drugs. These circumstances contribute to the suppression of the normal microbiota of the human body, an increase in antibiotic resistance of pathogens, an increase in the cost of treatment and the risk of adverse drug reactions. In acute non-streptococcal tonsillopharyngitis, antibacterial therapy is not indicated. Treatment of such patients should be directed to all links of etiopathogenesis, with the minimum sufficient use of drugs. Patients with viral ATP need effective relief of symptoms and prevention of bacterial complications. In this aspect, standardized herbal medicine can play an important role. Herbal drugs have a multicomponent effect, including anti-inflammatory, antiseptic, immunomodulatory and reparative effects. This makes them optimal agents for the therapy of viral inflammatory diseases of the pharynx. Particular attention should be paid to Tonsilgon N—the original herbal medicinal product with complex effect, produced by Bionorica company in Germany according to the unique concept of phytoneering. The staff of the Department of Ear, Throat and Nose Diseases of the Sechenov Moscow State Medical University studied the effectiveness of the Tonsilgon N use in the treatment of patients with acute non-bacterial tonsillopharyngitis. The results of the study showed that the use of Tonsilgon H in the treatment of patients with acute non-bacterial tonsillopharyngitis is safe and effective, and contributes to a faster reduction in the severity of clinical symptoms compared to the use of topical therapy alone.This publication has 15 references indexed in Scilit:
- Systematic review and meta-analysis of the accuracy of McIsaac and Centor score in patients presenting to secondary care with pharyngitisClinical Microbiology and Infection, 2024
- Evaluation of the clinical efficacy of the effect of herbal medicine on the symptoms of SARS-COV-2 associated pharyngitis and the formation of post-covid syndromeRussian Bulletin of Otorhinolaryngology, 2023
- Appropriateness of outpatient antibiotic prescribing among privately insured US patients: ICD-10-CM based cross sectional studyBMJ, 2019
- Variability in Antibiotic Prescribing for Upper Respiratory Illnesses by Provider SpecialtyThe Journal of Pediatrics, 2018
- Prevalence of Inappropriate Antibiotic Prescribing in Primary Care Clinics within a Veterans Affairs Health Care SystemAntimicrobial Agents and Chemotherapy, 2018
- Outpatient Antibiotic Prescribing for Acute Respiratory Infections During Influenza SeasonsJAMA Network Open, 2018
- Safety of reduced antibiotic prescribing for self limiting respiratory tract infections in primary care: cohort study using electronic health recordsBMJ, 2016
- Prevalence of Inappropriate Antibiotic Prescriptions Among US Ambulatory Care Visits, 2010-2011JAMA, 2016
- Over prescription of antibiotics for adult pharyngitis is prevalent in developing countries but can be reduced using McIsaac modification of Centor scores: a cross-sectional studyBMC Pulmonary Medicine, 2012
- Characterization of Viral Agents Causing Acute Respiratory Infection in a San Francisco University Medical Center Clinic during the Influenza SeasonClinical Infectious Diseases, 2005